Estigma percibido y calidad de vida relacionada con la salud en pacientes con diagnóstico de epilepsia en La Guajira
| datacite.rights | http://purl.org/coar/access_right/c_16ec | spa |
| dc.contributor.advisor | García Puello, Floralinda | |
| dc.contributor.advisor | Bermúdez Pirela, Valmore | |
| dc.contributor.author | Bravo Guzmán, Diana Judith | |
| dc.contributor.author | Zambrano León, José Antonio | |
| dc.date.accessioned | 2024-01-17T19:35:25Z | |
| dc.date.available | 2024-01-17T19:35:25Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Debido a la complejidad y curso crónico de la epilepsia, las personas con esta enfermedad se enfrentan a varios factores de carga social y psicológica que pueden ser generados por el estigma percibido, impactando en la calidad de vida relacionada con la salud mediante la discriminación y la autopercepción negativa. Objetivo: Analizar la relación entre el estigma percibido y el compromiso de la calidad de vida relacionada con la salud en pacientes con diagnóstico de epilepsia en el departamento de la Guajira. Metodología: Estudio cuantitativo, descriptivo transversal con fase analítica correlacional, constituido por 135 pacientes con diagnóstico de epilepsia de la Fundación Vida Con Amor IPS, en La Guajira Colombia. Resultados: El 50.4% fueron hombres; media de edad de 43 años y media de presentación de crisis epilépticas 24,8 años (DE:18,8), 59% presentaron estigma leve- moderado (p=0.8), 53% regular calidad de vida, relación 1:1 con el sexo (p=0.8). Existe correlación moderada entre el compromiso de la calidad de vida y el estigma percibido por la población de estudio (p<0,000). Conclusiones: Gran parte de la población se siente estigmatizada y más de la mitad tiene algún grado de compromiso en su calidad de vida relacionada con la salud, las variables clínicas que presentaron relación con dicha variable fueron: privación de sueño, cambios en la temperatura, etiología de la epilepsia y número de fármacos anticrisis, las situaciones estresantes fue la única que se relacionó con la calidad de vida y el estigma percibido. | spa |
| dc.description.abstract | Due to the complexity and chronic course of epilepsy, people with this condition face various social and psychological factors that can be generated by perceived stigma, impacting the human health related to the quality of life through discrimination and negative self-perception. Objective: To analyze the relationship between perceived stigma and the compromise of quality of life related to health in patients diagnosed with epilepsy in the department of La Guajira. Methodology: Quantitative study, cross-sectional descriptive study with correlational analytical phase, consisting of 135 patients with a diagnosis of epilepsy from the Foundation Vida con Amor IPS of La Guajira, Colombia. Results: 50.4% were male; age range 43 years and mean age of onset of epileptic seizures 24.8 years (SD: 18.8), 59% had mild-moderate stigma (p=0.8), 53% reported regular quality of life, with a 1:1 ratio between sexes (p=0.8). There is a moderate correlation between the compromise of quality of life and the perceived stigma by the study population (p<0.000). Conclusions: A significant part of the population feels stigmatized, and more than half have some degree of compromise in their health-related to quality of life. Clinical variables related to this, included sleep deprivation, changes in temperature, epilepsy etiology, and the number of anti-epileptic medications. Stressful situations were the only factor related to both quality of life and perceived stigma. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/13805 | |
| dc.language.iso | spa | spa |
| dc.publisher | Ediciones Universidad Simón Bolívar | spa |
| dc.publisher | Facultad de Ciencias de la Salud | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.subject | Epilepsia | spa |
| dc.subject | Calidad de vida | spa |
| dc.subject | Calidad de vida relacionada con la salud | spa |
| dc.subject | Estigma | spa |
| dc.subject | Epilepsy | eng |
| dc.subject | Quality of life | eng |
| dc.subject | Health-related quality of life | eng |
| dc.subject | Stigma | eng |
| dc.title | Estigma percibido y calidad de vida relacionada con la salud en pacientes con diagnóstico de epilepsia en La Guajira | spa |
| dc.type.driver | info:eu-repo/semantics/other | spa |
| dc.type.spa | Otros | spa |
| dcterms.references | Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82. http://dx.doi.org/10.1111/epi.12550 | eng |
| dcterms.references | Epilepsy. Who.int. [citado el 20 de marzo de 2023]. https://www.who.int/news-room/fact- sheets/detail/epilepsy | eng |
| dcterms.references | Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon C-S, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88(3):296–303. http://dx.doi.org/10.1212/wnl.0000000000003509 | eng |
| dcterms.references | Beghi E. The epidemiology of epilepsy. Neuroepidemiology. 2020;54(2):185–91. http://dx.doi.org/10.1159/000503831 | eng |
| dcterms.references | Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459–80. http://dx.doi.org/10.1016/s1474- 4422(18)30499-x | eng |
| dcterms.references | Beghi E, Giussani G, Nichols E, Abd-Allah F, Abdela J, Abdelalim A, et al. Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18(4):357–75. http://dx.doi.org/10.1016/s1474-4422(18)30454-x | eng |
| dcterms.references | Singh G, Sander JW. The global burden of epilepsy report: Implications for low- and middle-income countries. Epilepsy Behav. 2020;105(106949):106949. http://dx.doi.org/10.1016/j.yebeh.2020.106949 | eng |
| dcterms.references | Yacubian EMT, Kakooza-Mwesige A, Singh G, Carpio A, de Figueiredo NV, Lutzky Saute R, et al. Common infectious and parasitic diseases as a cause of seizures: geographic distribution and contribution to the burden of epilepsy. Epileptic Disord. 2022;24(6):994–1019. http://dx.doi.org/10.1684/epd.2022.1491 | eng |
| dcterms.references | Newton CR, Garcia HH. Epilepsy in poor regions of the world. Lancet. 2012;380(9848):1193–201. http://dx.doi.org/10.1016/s0140-6736(12)61381-6 | eng |
| dcterms.references | Falco-Walter J. Epilepsy—definition, classification, pathophysiology, and epidemiology. Semin Neurol. 2020;40(06):617–23. http://dx.doi.org/10.1055/s-0040-1718719 | eng |
| dcterms.references | Espinosa-Jovel C, Toledano R, Aledo-Serrano Á, García-Morales I, Gil-Nagel A. Epidemiological profile of epilepsy in low-income populations. Seizure. 2018; 56:67–72. http://dx.doi.org/10.1016/j.seizure.2018.02.002 | eng |
| dcterms.references | Alva-Díaz C, Navarro-Flores A, Rivera-Torrejon O, Huerta-Rosario A, Molina RA, Velásquez- Rimachi V, et al. Prevalence and incidence of epilepsy in Latin America and the Caribbean: A systematic review and meta‐analysis of population‐based studies. Epilepsia. 2021;62(4):984–96. http://dx.doi.org/10.1111/epi.16850 | eng |
| dcterms.references | Pacheco-Barrios K, Navarro-Flores A, Cardenas-Rojas A, de Melo PS, Uygur-Kucukseymen E, Alva-Diaz C, et al. Burden of epilepsy in Latin America and The Caribbean: a trend analysis of the Global Burden of Disease Study 1990 – 2019. Lancet Reg Health Am. 2022;8(100140):100140. http://dx.doi.org/10.1016/j.lana.2021.100140 | eng |
| dcterms.references | Méndez-Ayala A, Nariño D, Rosselli D. Burden of epilepsy in Colombia. Neuroepidemiology. 2015;44(3):144–8. http://dx.doi.org/10.1159/000381424 | eng |
| dcterms.references | Pinilla-Monsalve GD, Vergara-Aguilar JP, Machado-Noguera B, Gutiérrez-Baquero J, Cabezas- Vargas Z, Bejarano-Hernández J. Estudio de la epidemiología neurológica en Colombia a partir de información administrativa (ESENCIA). Resultados preliminares 2015-2017. Salud UIS . 20 de septiembre de 2021;53(1). https://revistas.uis.edu.co/index.php/revistasaluduis/article/view/11958 | spa |
| dcterms.references | SISPRO - Sistema integrado de información de la protección social. Gov.co. [citado el 9 de mayo de 2023]. https://www.sispro.gov.co/Pages/Home.aspx | spa |
| dcterms.references | Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40(6):593–600. http://dx.doi.org/10.1016/0021-9681(87)90019-1 | eng |
| dcterms.references | Baranowski CJ. The quality of life of older adults with epilepsy: A systematic review. Seizure. 2018;60:190–7. http://dx.doi.org/10.1016/j.seizure.2018.06.002 | eng |
| dcterms.references | Tombini M, Assenza G, Quintiliani L, Ricci L, Lanzone J, Di Lazzaro V. Epilepsy and quality of life: what does really matter? Neurol Sci. 2021;42(9):3757–65. http://dx.doi.org/10.1007/s10072- 020-04990-6 | eng |
| dcterms.references | Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: A systematic review: Quality of Life and Costs in Epilepsy. Epilepsia. 2011;52(12):2168–80. http://dx.doi.org/10.1111/j.1528-1167.2011.03213.x | eng |
| dcterms.references | Strzelczyk A, Aledo-Serrano A, Coppola A, Didelot A, Bates E, Sainz-Fuertes R, et al. The impact of epilepsy on quality of life: Findings from a European survey. Epilepsy Behav. 2023;142(109179):109179. http://dx.doi.org/10.1016/j.yebeh.2023.109179 | eng |
| dcterms.references | Palacios E, Vicuña M, Pulido AC, Vergara J paul. Calidad de vida en pacientes con epilepsia que son atendidos en el departamento de neurología del Hospital San José de Bogotá. Acta Neurológica Colomb. 31 de marzo de 2015;31(3):235-9. | spa |
| dcterms.references | Moreno Mayorga B, Vélez Botero H, Fandiño Franky J, Pérez Almanza N, Agudelo Hernández F, González González NY. Calidad de vida en personas con epilepsia. Más allá de las crisis. Rev Neurol. 2023;76(08):257. http://dx.doi.org/10.33588/rn.7608.2023052 | spa |
| dcterms.references | World Health Organization. WHO information kit on epilepsy: what you can do. World Health Organization; 2015. | eng |
| dcterms.references | Organización Mundial de la Salud. Epilepsia: un imperativo de salud pública: resumen. Organización Mundial de la Salud; 2019. | spa |
| dcterms.references | Empoderar a las personas con epilepsia para liderar la lucha contra la estigmatización. Ilae.org. [citado el 20 de octubre de 2023]. https://www.ilae.org/journals/epigraph/epigraph-vol-25-issue-2- spring-023/empoderar-a-las-personas-con-epilepsia-para-liderar-la-lucha-contra-la-estigmatizaci-n | spa |
| dcterms.references | Baker GA, Brooks J, Buck D, Jacoby A. The stigma of epilepsy: A European perspective. Epilepsia. 2000;41(1):98–104. http://dx.doi.org/10.1111/j.1528-1157.2000.tb01512.x | eng |
| dcterms.references | Aydemir N, Kaya B, Yıldız G, Öztura İ, Baklan B. Determinants of felt stigma in epilepsy. Epilepsy Behav. 2016;58:76–80. http://dx.doi.org/10.1016/j.yebeh.2016.03.008 | eng |
| dcterms.references | Kwon C-S, Jacoby A, Ali A, Austin J, Birbeck GL, Braga P, et al. Systematic review of frequency of felt and enacted stigma in epilepsy and determining factors and attitudes toward persons living with epilepsy—Report from the International League Against Epilepsy Task Force on Stigma in Epilepsy. Epilepsia. 2022;63(3):573–97. http://dx.doi.org/10.1111/epi.17135 | eng |
| dcterms.references | Lalatović S, Milovanović M, Krstić N. Stigma and its association with health-related quality of life in adults with epilepsy. Epilepsy Behav. 2022;135(108874):108874. http://dx.doi.org/10.1016/j.yebeh.2022.108874 | eng |
| dcterms.references | Thornicroft G, Sunkel C, Alikhon Aliev A, Baker S, Brohan E, el Chammay R, et al. The Lancet Commission on ending stigma and discrimination in mental health. Lancet. 2022;400(10361):1438– 80. http://dx.doi.org/10.1016/s0140-6736(22)01470-2 | eng |
| dcterms.references | Suurmeijer TPBM, Reuvekamp MF, Aldenkamp BP. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia. 2001;42(9):1160–8. http://dx.doi.org/10.1046/j.1528- 1157.2001.37000.x | eng |
| dcterms.references | Raúl N, Garzón R, Lonie C, Freyle G, Pulido A, Amalfis F, et al. Unidos por el Cambio. Obsgestioneducativa.com. [citado el 20 de octubre de 2023]. https://www.obsgestioneducativa.com/wp-content/uploads/2021/02/La-Guajira.pdf | spa |
| dcterms.references | Barros M, Igor M. Prevalencia y características de la epilepsia en Riohacha, departamento de la Guajira. Acta neurol colomb. 2001 [citado el 20 de octubre de 2023];24–7. https://pesquisa.bvsalud.org/portal/resource/pt/lil-307271 | spa |
| dcterms.references | Fayers P, Machin D. Quality of Life: The assessment, analysis and interpretation of patient-reported outcomes. 2 ed. Chichester: John Wiley & Sons, 2007. 544 p. | eng |
| dcterms.references | Kaplan RM, Hays RD. Health-related quality of life measurement in public health. Annu Rev Public Health. 2022;43(1):355–73. http://dx.doi.org/10.1146/annurev-publhealth-052120-012811 | eng |
| dcterms.references | Fisher RS, Boas W van E, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for epilepsy (IBE). Epilepsia. 2005;46(4):470–2. http://dx.doi.org/10.1111/j.0013- 9580.2005.66104.x | eng |
| dcterms.references | Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522–30. http://dx.doi.org/10.1111/epi.13670 | eng |
| dcterms.references | Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–21. http://dx.doi.org/10.1111/epi.13709 | eng |
| dcterms.references | Falco-Walter JJ, Scheffer IE, Fisher RS. The new definition and classification of seizures and epilepsy. Epilepsy Res. 2018;139:73–9. http://dx.doi.org/10.1016/j.eplepsyres.2017.11.015 | eng |
| dcterms.references | Wirrell E. Evaluation of first seizure and newly diagnosed epilepsy. Continuum (Minneap Minn). 2022;28(2):230–60. http://dx.doi.org/10.1212/con.0000000000001074 | eng |
| dcterms.references | Thijs RD, Surges R, O’Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689–701. http://dx.doi.org/10.1016/s0140-6736(18)32596-0 | eng |
| dcterms.references | Asadi-Pooya AA, Brigo F, Lattanzi S, Blumcke I. Adult epilepsy. Lancet. 2023;402(10399):412– 24. http://dx.doi.org/10.1016/s0140-6736(23)01048-6 | eng |
| dcterms.references | Asadi-Pooya AA, Simani L. Epilepsy syndromes in Iran: A systematic review. Acta Neurol Scand. 2021;143(5):475–80. http://dx.doi.org/10.1111/ane.13381 | eng |
| dcterms.references | Asadi-Pooya AA, Stewart GR, Abrams DJ, Sharan A. Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States. World Neurosurg. 2017;99:662–6. http://dx.doi.org/10.1016/j.wneu.2016.12.074 | eng |
| dcterms.references | Watila MM, Balarabe SA, Ojo O, Keezer MR, Sander JW. Overall and cause-specific premature mortality in epilepsy: A systematic review. Epilepsy Behav. 2018;87:213–25. http://dx.doi.org/10.1016/j.yebeh.2018.07.017 | eng |
| dcterms.references | Walsh S, Donnan J, Fortin Y, Sikora L, Morrissey A, Collins K, et al. A systematic review of the risks factors associated with the onset and natural progression of epilepsy. Neurotoxicology. 2017;61:64–77. http://dx.doi.org/10.1016/j.neuro.2016.03.011 | eng |
| dcterms.references | Zhang C, Wang X, Wang Y, Zhang J-G, Hu W, Ge M, et al. Risk factors for post-stroke seizures: A systematic review and meta-analysis. Epilepsy Res. 2014;108(10):1806–16. http://dx.doi.org/10.1016/j.eplepsyres.2014.09.030 | eng |
| dcterms.references | Sequeira-Quesada C, Delgado-Gómez D, Céspedes-Valverde M, Chaves-Jimenez M. La epilepsia y factores de riesgo: una revisión narrativa . Rev Hisp Cienc Salud. 17 de febrero de 2023 [citado 20 de octubre de 2023];9(1):42-51. https://uhsalud.com/index.php/revhispano/article/view/597 | spa |
| dcterms.references | Yang L, Wang Y, Chen X, Zhang C, Chen J, Cheng H, et al. Risk factors for epilepsy: A national cross-sectional study from national health and nutrition examination survey 2013 to 2018. Int J Gen Med. 2021;14:4405–11. http://dx.doi.org/10.2147/ijgm.s323209 | eng |
| dcterms.references | Ferlazzo E, Gasparini S, Beghi E, Sueri C, Russo E, Leo A, et al. Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta‐analysis of risk factors. Epilepsia. 2016;57(8):1205–14. http://dx.doi.org/10.1111/epi.13448 | eng |
| dcterms.references | Zhang P, Yang Y, Zou J, Yang X, Liu Q, Chen Y. Seizures and epilepsy secondary to viral infection in the central nervous system. Acta Epileptologica. 2020;2(1). http://dx.doi.org/10.1186/s42494- 020-00022-0 | eng |
| dcterms.references | Xu T, Yu X, Ou S, Liu X, Yuan J, Huang H, et al. Risk factors for posttraumatic epilepsy: A systematic review and meta-analysis. Epilepsy Behav. 2017;67:1–6. http://dx.doi.org/10.1016/j.yebeh.2016.10.026 | eng |
| dcterms.references | Seidel S, Wehner T, Miller D, Wellmer J, Schlegel U, Grönheit W. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication. Neurol Res Pract. 2022;4(1). http://dx.doi.org/10.1186/s42466-022-00205-9 | eng |
| dcterms.references | van der Meer PB, Taphoorn MJB, Koekkoek JAF. Management of epilepsy in brain tumor patients. Curr Opin Oncol. 2022;34(6):685–90. http://dx.doi.org/10.1097/cco.0000000000000876 | eng |
| dcterms.references | Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine. 2022;82(104154):104154. http://dx.doi.org/10.1016/j.ebiom.2022.104154 | eng |
| dcterms.references | Zhang Z, Wang M, Yuan S, Liu X. Alcohol, coffee, and milk intake in relation to epilepsy risk. Nutrients. 2022;14(6):1153. http://dx.doi.org/10.3390/nu14061153 | eng |
| dcterms.references | Ferlisi M, Shorvon S. Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy Behav. 2014;33:101–5. http://dx.doi.org/10.1016/j.yebeh.2014.02.019 | eng |
| dcterms.references | Koutroumanidis M, Arzimanoglou A, Caraballo R, Goyal S, Kaminska A, Laoprasert P, et al. The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 1). Epileptic Disord. 2017;19(3):233–98. http://dx.doi.org/10.1684/epd.2017.0935 | eng |
| dcterms.references | Samsonsen C, Mestvedthagen G, Uglem M, Brodtkorb E. Disentangling the cascade of seizure precipitants: A prospective observational study. Epilepsy Behav. 2023;145(109339):109339. http://dx.doi.org/10.1016/j.yebeh.2023.109339 | eng |
| dcterms.references | Pitkänen A, Lukasiuk K, Dudek FE, Staley KJ. Epileptogenesis. Cold Spring Harb Perspect Med. 2015;5(10):a022822. http://dx.doi.org/10.1101/cshperspect.a022822 | eng |
| dcterms.references | Donaire A, Capdevila A, Carreño M, Setoain X, Rumià J, Aparicio J, et al. Identifying the cortical substrates of interictal epileptiform activity in patients with extratemporal epilepsy: An EEG‐fMRI sequential analysis and FDG‐PET study. Epilepsia. 2013;54(4):678–90. http://dx.doi.org/10.1111/epi.12091 | eng |
| dcterms.references | Li L, He L, Harris N, Zhou Y, Engel J Jr, Bragin A. Topographical reorganization of brain functional connectivity during an early period of epileptogenesis. Epilepsia. 2021;62(5):1231–43. http://dx.doi.org/10.1111/epi.16863 | eng |
| dcterms.references | Chen G, Zhang Z, Wang M, Geng Y, Jin B, Aung T. Update on the neuroimaging and electroencephalographic biomarkers of epileptogenesis: A literature review. Front Neurol. 2021;12. http://dx.doi.org/10.3389/fneur.2021.738658 | eng |
| dcterms.references | Prior MJ de A-A, García MR, Navarro JO, Singer PA. Epilepsia: generalidades sobre las crisis epilépticas y la epilepsia. Medicine. 2023;13(72):4205–19. http://dx.doi.org/10.1016/j.med.2023.02.010 | spa |
| dcterms.references | Blümcke I, Aronica E, Miyata H, Sarnat HB, Thom M, Roessler K, et al. International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: A consensus Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2016;57(3):348–58. http://dx.doi.org/10.1111/epi.13319 | eng |
| dcterms.references | Balestrini S, Arzimanoglou A, Blümcke I, Scheffer IE, Wiebe S, Zelano J, et al. The aetiologies of epilepsy. Epileptic Disord. 2021;23(1):1–16. http://dx.doi.org/10.1684/epd.2021.1255 | eng |
| dcterms.references | Steel D, Symonds JD, Zuberi SM, Brunklaus A. Dravet syndrome and its mimics: Beyond SCN1A. Epilepsia. 2017;58(11):1807–16. http://dx.doi.org/10.1111/epi.13889 | eng |
| dcterms.references | Burton PR, Tobin MD, Hopper JL. Key concepts in genetic epidemiology. Lancet. 2005;366(9489):941–51. http://dx.doi.org/10.1016/s0140-6736(05)67322-9 | eng |
| dcterms.references | Olivé-Gadea M, Requena M, Fonseca Hernández E, Quintana M, Santamarina E, Abraira del Fresno L, et al. Etiology, seizure type, and prognosis of epileptic seizures in the emergency department. Epilepsy Behav. 2019;92:327–31. http://dx.doi.org/10.1016/j.yebeh.2018.12.008 | eng |
| dcterms.references | Campistol J, Plecko B. Treatable newborn and infant seizures due to inborn errors of metabolism. Epileptic Disord. 2015;17(3):229–42. http://dx.doi.org/10.1684/epd.2015.0754 | eng |
| dcterms.references | Assi L, Saklawi Y, Karam PE, Obeid M. Treatable genetic metabolic epilepsies. Curr Treat Options Neurol. 2017;19(9). http://dx.doi.org/10.1007/s11940-017-0467-0 | eng |
| dcterms.references | Dulac O, Plecko B, Gataullina S, Wolf NI. Occasional seizures, epilepsy, and inborn errors of metabolism. Lancet Neurol. 2014;13(7):727–39. http://dx.doi.org/10.1016/s1474-4422(14)70110-3 | eng |
| dcterms.references | Greco A, Rizzo MI, De Virgilio A, Conte M, Gallo A, Attanasio G, et al. Autoimmune epilepsy. Autoimmun Rev. 2016;15(3):221–5. http://dx.doi.org/10.1016/j.autrev.2015.11.007 | eng |
| dcterms.references | Graus F, Vogrig A, Muñiz-Castrillo S, Antoine J-CG, Desestret V, Dubey D, et al. Updated diagnostic criteria for paraneoplastic neurologic syndromes. Neurol Neuroimmunol Neuroinflamm. 2021;8(4):e1014. http://dx.doi.org/10.1212/nxi.0000000000001014 | eng |
| dcterms.references | National Institute for Healt and Care Excellence. Epilepsies: diagnosis and management | Guidance | NICE. 2012. http://www.nice.org.uk/guidance/cg137 | eng |
| dcterms.references | Koutroumanidis M, Arzimanoglou A, Caraballo R, Goyal S, Kaminska A, Laoprasert P, et al. The role of EEG in the diagnosis and classification of the epilepsy syndromes: a tool for clinical practice by the ILAE Neurophysiology Task Force (Part 2). Epileptic Disord. 2017;19(4):385–437. http://dx.doi.org/10.1684/epd.2017.0952 | eng |
| dcterms.references | Wellmer J, Quesada CM, Rothe L, Elger CE, Bien CG, Urbach H. Proposal for a magnetic resonance imaging protocol for the detection of epileptogenic lesions at early outpatient stages. Epilepsia. 2013;54(11):1977–87. http://dx.doi.org/10.1111/epi.12375 | eng |
| dcterms.references | von Oertzen J. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 2002;73(6):643–7. http://dx.doi.org/10.1136/jnnp.73.6.643 | eng |
| dcterms.references | Trinka E, Brigo F. Antiepileptogenesis in humans: Disappointing clinical evidence and ways to move forward. Curr Opin Neurol. 2014;27(2):227–35. http://dx.doi.org/10.1097/wco.0000000000000067 | eng |
| dcterms.references | French JA, Perucca E. Time to start calling things by their own names? The case for antiseizure medicines. Epilepsy Curr. 2020;20(2):69–72. http://dx.doi.org/10.1177/1535759720905516 | eng |
| dcterms.references | Brigo F, Marson A. Approach to the medical treatment of epilepsy. Continuum (Minneap Minn). 2022;28(2):483–99. http://dx.doi.org/10.1212/con.0000000000001081 | eng |
| dcterms.references | Kanner AM, Bicchi MM. Antiseizure medications for adults with epilepsy: A review. JAMA. 2022;327(13):1269. http://dx.doi.org/10.1001/jama.2022.3880 | eng |
| dcterms.references | Fernández-López JA, Fernández-Fidalgo M, Cieza A. Los conceptos de calidad de vida, salud y bienestar analizados desde la perspectiva de la Clasificación Internacional del Funcionamiento (CIF). Rev Esp Salud Publica. 2010;84(2):169–84. https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1135-57272010000200005 | spa |
| dcterms.references | de Mejía BEB, Merchán MEP. Calidad de vida relacionada con la salud (CVRS) en adultos mayores de 60 años: Una aproximación teórica. Hacia Promoc Salud. 2007;12:11–24. https://revistasojs.ucaldas.edu.co/index.php/hacialapromociondelasalud/article/view/1944 | spa |
| dcterms.references | OMS. ¿Que calidad de vida? Foro Mundial de Ia Salud. 1996; https://iris.who.int/bitstream/handle/10665/55264/WHF_1996_17_n4_p385- 387_spa.pdf?isAllowed=y&sequence=1 | spa |
| dcterms.references | Haraldstad K, the LIVSFORSK network, Wahl A, Andenæs R, Andersen JR, Andersen MH, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 2019;28(10):2641–50. http://dx.doi.org/10.1007/s11136-019-02214-9 | eng |
| dcterms.references | Urzúa M A, Caqueo-Urízar A. Calidad de vida: Una revisión teórica del concepto. Ter Psicol. 2012;30(1):61–71. http://dx.doi.org/10.4067/s0718-48082012000100006 | spa |
| dcterms.references | Patrick, Donald L, Erickson, Pennifer. Health status and health policy: Quality of life in health care evaluation and resource allocation. 1993 https://repository.library.georgetown.edu/handle/10822/860706 | eng |
| dcterms.references | Pequeno NPF, Cabral NL de A, Marchioni DM, Lima SCVC, Lyra C de O. Quality of life assessment instruments for adults: a systematic review of population-based studies. Health Qual Life Outcomes. 2020;18(1). http://dx.doi.org/10.1186/s12955-020-01347-7 | eng |
| dcterms.references | Monica 1776 Main Street Santa, California 90401-3208. Quality of Life in Epilepsy Inventory (QOLIE-89 and QOLIE-31). [citado 18 de septiembre de 2023]. https://www.rand.org/health- care/surveys_tools/qolie.html | eng |
| dcterms.references | Shakhatreh L, Foster E, Siriratnam P, Neal A, Carney PW, Jackson GD, et al. Impact of epilepsy surgery on quality of life: Systematic review and meta‐analysis. Epilepsia. 2023;64(7):1709– 21.http://dx.doi.org/10.1111/epi.17644 | eng |
| dcterms.references | Cramer JA, Arrigo C, Van Hammée G, Bromfield EB. Comparison between the QOLIE-31 and derived QOLIE-10 in a clinical trial of levetiracetam. Epilepsy Res. 2000;41(1):29– 38.http://dx.doi.org/10.1016/s0920-1211(00)00127-3 | eng |
| dcterms.references | Cano-López I, Hampel KG, Garcés M, Villanueva V, González-Bono E. Quality of life in drug- resistant epilepsy: relationships with negative affectivity, memory, somatic symptoms and social support. J Psychosom Res. 2018;114:31–7. http://dx.doi.org/10.1016/j.jpsychores.2018.09.001 | eng |
| dcterms.references | Tomson T, Walczak T, Sillanpaa M, Sander JWAS. Sudden unexpected death in epilepsy: A review of incidence and risk factors. Epilepsia. 2005;46(s11):54–61.http://dx.doi.org/10.1111/j.1528- 1167.2005.00411.x | eng |
| dcterms.references | Deleo F, Quintas R, Pastori C, Pappalardo I, Didato G, Di Giacomo R, et al. Quality of life, psychiatric symptoms, and stigma perception in three groups of persons with epilepsy. Epilepsy Behav. 2020;110(107170):107170. http://dx.doi.org/10.1016/j.yebeh.2020.107170 | eng |
| dcterms.references | Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993;34(2):312–22. http://dx.doi.org/10.1111/j.1528- 1157.1993.tb02417.x | eng |
| dcterms.references | Punia V, Sheikh SR, Thompson NR, Bingaman W, Jehi L. Quality of life before and after epilepsy surgery: Age is just a number. Epilepsy Behav. 2020;113(107574):107574. http://dx.doi.org/10.1016/j.yebeh.2020.107574 | eng |
| dcterms.references | Spencer SS, Berg AT, Vickrey BG, Sperling MR, Bazil CW, Haut S, et al. Health‐related quality of life over time since resective epilepsy surgery. Ann Neurol. 2007;62(4):327– 34.http://dx.doi.org/10.1002/ana.21131 | eng |
| dcterms.references | Goffman E. Stigma: Notes on the management of spoiled identity. Nueva York, NY, Estados Unidos de América: Touchstone; 1986. | eng |
| dcterms.references | Thomas S, Nair A. Confronting the stigma of epilepsy. Ann Indian Acad Neurol. 2011;14(3):158. http://dx.doi.org/10.4103/0972-2327.85873 | eng |
| dcterms.references | Weiss MG, Ramakrishna J, Somma D. Health-related stigma: Rethinking concepts and interventions 1. Psychol Health Med. 2006;11(3):277–87. http://dx.doi.org/10.1080/13548500600595053 | eng |
| dcterms.references | Subu MA, Wati DF, Netrida N, Priscilla V, Dias JM, Abraham MS, et al. Types of stigma experienced by patients with mental illness and mental health nurses in Indonesia: a qualitative content analysis. Int J Ment Health Syst. 2021;15(1).http://dx.doi.org/10.1186/s13033-021-00502- x | eng |
| dcterms.references | Scambler G, Hopkins A. Being epileptic: coming to terms with stigma. Sociol Health Illn. 1986;8(1):26–43.http://dx.doi.org/10.1111/1467-9566.ep11346455 | eng |
| dcterms.references | Rank WP. Standing up to stigma in epilepsy. Nursing. 2020;50(7):48– 52.http://dx.doi.org/10.1097/01.nurse.0000659324.50792.71 | eng |
| dcterms.references | Jacoby A. Epilepsy and the quality of everyday life. Soc Sci Med 1992;34(6):657–66. http://dx.doi.org/10.1016/0277-9536(92)90193-t | eng |
| dcterms.references | Bautista RED, Shapovalov D, Shoraka AR. Factors associated with increased felt stigma among individuals with epilepsy. Seizure. 2015;30:106–12. http://dx.doi.org/10.1016/j.seizure.2015.06.006 | eng |
| dcterms.references | Yeni K, Tulek Z, Simsek OF, Bebek N. Relationships between knowledge, attitudes, stigma, anxiety and depression, and quality of life in epilepsy: A structural equation modeling. Epilepsy Behav. 2018;85:212–7. http://dx.doi.org/10.1016/j.yebeh.2018.06.019 | eng |
| dcterms.references | Alvaréz Cam. Metodología de la investigación cuantitativa y cualitativa. 2011. https://www.uv.mx/rmipe/files/2017/02/Guia-didactica-metodologia-de-la-investigacion.pdf | spa |
| dcterms.references | Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy the QOLIE-10. Epilepsia. 1996;37(6):577–82. http://dx.doi.org/10.1111/j.1528- 1157.1996.tb00612.x | eng |
| dcterms.references | Barranco Camargo LA, Usta Agamez E, López García J, Jurado López S, Zabala Caraballo C, Ramos Clason E. Validez y fiabilidad del instrumento para evaluación de calidad de vida relacionada con la salud en epilepsia QOLIE-10 en pacientes adultos con epilepsia refractaria en un centro neurológico colombiano. Rev Neurol. 2019;69(12):473. http://dx.doi.org/10.33588/rn.6912.2019273 | spa |
| dcterms.references | Taylor J, Baker GA, Jacoby A. Levels of epilepsy stigma in an incident population and associated factors. Epilepsy Behav. 2011;21(3):255–60. http://dx.doi.org/10.1016/j.yebeh.2011.04.002 | eng |
| dcterms.references | Baker GA, Brooks J, Buck D, Jacoby A. The stigma of epilepsy: A European perspective. Epilepsia. 2000;41(1):98–104. http://dx.doi.org/10.1111/j.1528-1157.2000.tb01512.x | eng |
| dcterms.references | Salado Medina V, López Espuela F, Falcón García A, Rico Martín S, Gómez Luque A, Casado Naranjo I. Valoración de la calidad de vida, estigma social y adhesión al tratamiento en pacientes con epilepsia del Área de Salud de Cáceres: estudio transversal. Rev Neurol. 2018;67(08):281. http://dx.doi.org/10.33588/rn.6708.2018073 | spa |
| dcterms.references | Shlobin NA, Sander JW. Learning from the comorbidities of epilepsy. Curr Opin Neurol. 2022;35(2):175–80. http://dx.doi.org/10.1097/wco.0000000000001010 | eng |
| dcterms.references | Wilner AN, Sharma BK, Soucy A, Thompson A, Krueger A. Common comorbidities in women and men with epilepsy and the relationship between number of comorbidities and health plan paid costs in 2010. Epilepsy Behav. 2014;32:15–20. http://dx.doi.org/10.1016/j.yebeh.2013.12.032 | eng |
| dcterms.references | Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44(11):2105–2105. http://dx.doi.org/10.1212/wnl.44.11.2105 | eng |
| dcterms.references | Kwon O-Y, Park S-P. Depression and anxiety in people with epilepsy. J Clin Neurol. 2014;10(3):175. http://dx.doi.org/10.3988/jcn.2014.10.3.175 | eng |
| dcterms.references | ekle-Haimanot R, Forsgren L, Ekstedt J. Incidence of epilepsy in rural central Ethiopia. Epilepsia. 1997;38(5):541–6. http://dx.doi.org/10.1111/j.1528-1157.1997.tb01138.x | eng |
| dcterms.references | Suurmeijer TPBM, Reuvekamp MF, Aldenkamp BP. Social functioning, psychological functioning, and quality of life in epilepsy. Epilepsia. 2001;42(9):1160–8. http://dx.doi.org/10.1046/j.1528- 1157.2001.37000.x | eng |
| dcterms.references | McLaughlin DP, Pachana NA, Mcfarland K. Stigma, seizure frequency and quality of life: The impact of epilepsy in late adulthood. Seizure. 2008;17(3):281–7. http://dx.doi.org/10.1016/j.seizure.2007.09.001 | eng |
| dcterms.references | Kumari P, Ram D, Haque Nizamie S, Goyal N. Stigma and quality of life in individuals with epilepsy: A preliminary report. Epilepsy Behav. 2009;15(3):358–61. http://dx.doi.org/10.1016/j.yebeh.2009.05.003 | eng |
| dcterms.references | Whatley AD, DiIorio CK, Yeager K. Examining the relationships of depressive symptoms, stigma, social support and regimen-specific support on quality of life in adult patients with epilepsy. Health Educ Res. 2010;25(4):575–84. Disponible en: http://dx.doi.org/10.1093/her/cyq001. | eng |
| dcterms.references | Grant AC, Prus N, Nakhutina L. Factors affecting quality of life in epilepsy in a multiethnic urban population. Epilepsy Behav. 1 de mayo de 2013;27(2):283-5. http://dx.doi.org/10.1016/j.yebeh.2013.01.031 | eng |
| oaire.version | info:eu-repo/semantics/acceptedVersion | spa |
| sb.programa | Especialización en Neurología | spa |
| sb.sede | Sede Barranquilla | spa |